women's health

News

MSD’s maternal health initiative passes big milestone

A $650 million programme set up by pharma group MSD to help prevent maternal mortality and improve health equity around the world has reached over 30 million women, easily

Digital

Women’s health and digital tech empowerment

Digital health tools have become a staple in many people’s efforts to stay healthy, not least during the pandemic.

Patients

Ending the silence: Why the menopause matters in the workpla...

One of the biggest challenges for women in their 40s and 50s going through the menopause is the recognition that one size does not fit all.

Patients

The unmentionables: Challenging inequalities in women’s heal...

As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, bu

News

Bayer cues up filings for rival to Astellas’ menopause drug

Armed with new phase 3 data, Bayer has started preparing filings for elinzanetant as a treatment for vasomotor symptoms (VMS) associated with menopause, setting up a chall

News

OS data set up wider Jemperli use in endometrial cancer

GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in th

MSD’s maternal health initiative passes big milestone

Women’s health and digital tech empowerment

Ending the silence: Why the menopause matters in the workpla...

The unmentionables: Challenging inequalities in women’s heal...

Bayer cues up filings for rival to Astellas’ menopause drug

OS data set up wider Jemperli use in endometrial cancer

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

women's health

Editor's Picks